Zydus Cadilla gets USFDA nod to market generic HIV treatment tablets

Company |  News | 0 Comment | 16 Nov, 2018

Drug firm Zydus Cadila has said that it has received final approval from the US health regulator to market generic Abacavir and Lamivudine tablets used for treatment of a type of HIV infect...Read more

Lupin receives FDA nod for blood cells disorder drug

Company |  News | 0 Comment | 15 Nov, 2018

Pharma major Lupin announced that it has received approval for its Decitabine for Injection, 50 mg/vial, Single-Dose Vial from the United States Food and Drug Administration (FDA) to market...Read more

Aurobindo Pharma to acquire Australian firm's product

Company |  News | 0 Comment | 14 Nov, 2018

Aurobindo Pharma has said it's wholly-owned subsidiary has entered into an agreement to acquire a product under development and related assets from Australia-based Advent Pharmaceuticals Pt...Read more

Suven secures product patents in Australia, Hong Kong

Company |  News | 0 Comment | 14 Nov, 2018

Suven Life Sciences Ltd (Suven) recently announced that the grant of one product patent from Australia (2016276139) and one product patent from Hong Kong (HK1217483) corresponding to the Ne...Read more

InvaGen announces acquisition agreement with Avenue Therapeutics

Company |  News | 0 Comment | 13 Nov, 2018

InvaGen Pharmaceuticals Inc., a subsidiary of the leading global pharmaceutical company Cipla Limited, has announced that it has entered into definitive agreements with two closing stages f...Read more

Cipla gets USFDA nod for pain relief gel of osteoarthritis

Company |  News | 0 Comment | 12 Nov, 2018

Drug major Cipla has received final approval from the United States Food and Drug Administration (USFDA) for Diclofenac Sodium Topical Gel, indicated for the relief of the pain of osteoarth...Read more

Lupin gets EIR from USFDA for Nagpur facility

Company |  News | 0 Comment | 12 Nov, 2018

Pharma major Lupin has announced the receipt of the Establishment Inspection report (EIR) post the completion of a Pre-Approval Inspection (PAI) for its Phenytoin Sodium Extended Release 10...Read more

Lilly, NextCure to develop novel immuno-onco medicines

Company |  News | 0 Comment | 06 Nov, 2018

Eli Lilly and Company and NextCure, Inc. have announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies. The collaboration seeks to discover...Read more

FDA completes successful inspection of DCA Bavla site

Company |  News | 0 Comment | 06 Nov, 2018

India-based Dishman Carbogen Amcis Limited (DCA), a global outsourcing partner for the pharmaceutical industry, has announced that its manufacturing and development facility in Bavla, Gujar...Read more

Nephroplus acquires DaVita Care India

Company |  News | 0 Comment | 05 Nov, 2018

NephroPlus, India’s largest dialysis care network and a trailblazer in redefining dialysis care in India announced the acquisition of DaVita Care India, part of DaVita Inc., a Fortune...Read more

Lupin recalls 6,752 bottles of Testosterone Topical solution from U.S.

Company |  News | 0 Comment | 05 Nov, 2018

The US arm of drug firm Lupin is recalling 6,752 bottles of Testosterone Topical solution from the American market on account of defective container, the USFDA said. The product is indicate...Read more

Aurobindo initiates to recall oncogenic hypertension drug

Company |  News | 0 Comment | 05 Nov, 2018

Aurobindo Pharma Limited has initiated voluntary recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension, from the US market due to the presence of an impurity,...Read more

Roche's new drugs will replace lost sales: Schwan

Company |  News | 0 Comment | 05 Nov, 2018

Roche Chief Executive Severin Schwan said new drugs the pharma company is developing will replace the roughly 10 billion Swiss francs ($9.97 billion) lost from old cancer dru...Read more

Zydus Cadila launches generic erectile dysfunction drug in US

Company |  News | 1 Comment | 02 Nov, 2018

Drug firm Zydus Cadila has said that it has launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the American market. The company has launche...Read more

Glenmark launches Nourkrin to treat hair loss in Russia

Company |  News | 0 Comment | 01 Nov, 2018

Glenmark Pharmaceuticals, a research-led globally integrated pharmaceutical company, today announced the launch of Nourkrin in Russia. Nourkrin is a globally renowned, clinically-proven pro...Read more

TAKE Solutions Q2 net profit up by 65.68%

Company |  News | 0 Comment | 01 Nov, 2018

TAKE Solutions, a globally recognized domain intensive services provider in Life Sciences, announced its financial results for Quarter and Half-Year ending 30th September 2018. The company ...Read more

Dr.Reddy’s launches Atomoxetine Capsules, USP in the U.S. Market

Company |  News | 0 Comment | 31 Oct, 2018

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s” today announced the launch of Atomoxetine Capsules, USP, a therapeut...Read more

Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil

Company |  News | 0 Comment | 30 Oct, 2018

Glenmark Pharmaceuticals has said that it has received final approval from the US health regulator for generic version of Derma-Smoothe Topical Oil, used in the treatment of scalp psoriasis...Read more